Randomized, Parallel Group, Double-blind Trial to Evaluate Different Dose Combinations of Lercanidipine and Enalapril in Comparison With Each Component Administered Alone and With Placebo in Patients With Essential Hypertension.
Phase of Trial: Phase II
Latest Information Update: 01 Jan 2016
At a glance
- Drugs Enalapril (Primary) ; Lercanidipine (Primary)
- Indications Essential hypertension
- Focus Therapeutic Use
- Acronyms FELT
- Sponsors Recordati
- 29 Apr 2012 Results presented at the 22nd European Meeting on Hypertension.
- 21 Apr 2012 Additional locations (Germany, Poland, Spain) added as reported by European Clinical Trials Database record.
- 28 Apr 2011 Actual end date (April 2011) added as reported by ClinicalTrials.gov.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History